Half-year report · HY
2531.TEDINET S100X1G2
Period2025-04-01 → 2025-09-30
Filed2025-11-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥186.6bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥362.7bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥176.5bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥7.8bn | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥10.5bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥7.4bn | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥22.2bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥11.2bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥8.6bn | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥13.7bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥5.7bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥16.2bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥9.1bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥3.3bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥9.7bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥476.6bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥477.6bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥447.8bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥189.2bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥176.7bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥287.5bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥300.9bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥296.5bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥60.6bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥83.3bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥54.0bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥75.3bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥89.9bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥90.2bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥6.0bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥16.2bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥6.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥18.4bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥41.6bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.3bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥6.8bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥6.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥9.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥29.4 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥82.98 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥46.55 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 49.8% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.3% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.0% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 54
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-04-01 → 2025-09-30 | ¥15.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-04-01 → 2025-09-30 | ¥7.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥8.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-04-01 → 2025-09-30 | ¥1.7bn |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2025-09-30 | −¥9.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2025-09-30 | −¥9.5bn |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | −¥702m |
| Takara Bio Groupreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥103.9bn |
| Takara Bio Groupreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥103.7bn |
| Takara Bio Groupreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥177m |
| Takara Bio Groupreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥6.7bn |
| Takara Healthcarereportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥18.8bn |
| Takara Healthcarereportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥18.8bn |
| Takara Healthcarereportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥0 |
| Takara Healthcarereportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥2.3bn |
| Takara Shuzo Groupreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥57.8bn |
| Takara Shuzo Groupreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥57.1bn |
| Takara Shuzo Groupreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥679m |
| Takara Shuzo Groupreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥2.5bn |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥180.4bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥179.6bn |
| —segment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥857m |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥6.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥196.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥186.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥9.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥8.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-09-30 | ¥15.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥6.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥8.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥1.4bn |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥9.6bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥9.6bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥395m |
| Takara Bio Groupreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥89.0bn |
| Takara Bio Groupreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥88.8bn |
| Takara Bio Groupreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥227m |
| Takara Bio Groupreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥6.5bn |
| Takara Healthcarereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥19.8bn |
| Takara Healthcarereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥19.8bn |
| Takara Healthcarereportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥0 |
| Takara Healthcarereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥417m |
| Takara Shuzo Groupreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥62.0bn |
| Takara Shuzo Groupreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥61.5bn |
| Takara Shuzo Groupreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥504m |
| Takara Shuzo Groupreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥2.6bn |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥170.7bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥170.0bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥732m |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥9.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥186.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥176.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥9.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥10.9bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 517
| Item | Context | Value | Unit |
|---|---|---|---|
| Allowance for doubtful accounts ca | Prior1YearInstant | -739000000 | JPY |
| Allowance for doubtful accounts ca | InterimInstant | -794000000 | JPY |
| Current assets | Prior1YearInstant | 245433000000 | JPY |
| Current assets | InterimInstant | 224183000000 | JPY |
| Property plant and equipment | Prior1YearInstant | 123610000000 | JPY |
| Property plant and equipment | InterimInstant | 128929000000 | JPY |
| Goodwill | Prior1YearInstant | 25283000000 | JPY |
| Goodwill | InterimInstant | 30096000000 | JPY |
| Other ia | Prior1YearInstant | 16378000000 | JPY |
| Other ia | InterimInstant | 27679000000 | JPY |
| Intangible assets | Prior1YearInstant | 41662000000 | JPY |
| Intangible assets | InterimInstant | 57775000000 | JPY |
| Investment securities | Prior1YearInstant | 34467000000 | JPY |
| Investment securities | InterimInstant | 35648000000 | JPY |
| Other ioa | Prior1YearInstant | 32474000000 | JPY |
| Other ioa | InterimInstant | 30135000000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant | -60000000 | JPY |
| Allowance for doubtful accounts ioa by group | InterimInstant | -61000000 | JPY |
| Investments and other assets | Prior1YearInstant | 66880000000 | JPY |
| Investments and other assets | InterimInstant | 65722000000 | JPY |
| Noncurrent assets | Prior1YearInstant | 232154000000 | JPY |
| Noncurrent assets | InterimInstant | 252428000000 | JPY |
| Assets | Prior1YearInstant | 477587000000 | JPY |
| Assets | InterimInstant | 476611000000 | JPY |
| Notes and accounts payable trade | Prior1YearInstant | 24067000000 | JPY |
| Notes and accounts payable trade | InterimInstant | 23841000000 | JPY |
| Short term loans payable | Prior1YearInstant | 12315000000 | JPY |
| Short term loans payable | InterimInstant | 6347000000 | JPY |
| Income taxes payable | Prior1YearInstant | 2742000000 | JPY |
| Income taxes payable | InterimInstant | 3706000000 | JPY |
| Provision cl | Prior1YearInstant | 3826000000 | JPY |
| Provision cl | InterimInstant | 3293000000 | JPY |
| Other cl | Prior1YearInstant | 30468000000 | JPY |
| Other cl | InterimInstant | 30426000000 | JPY |
| Current liabilities | Prior1YearInstant | 73419000000 | JPY |
| Current liabilities | InterimInstant | 67616000000 | JPY |
| Bonds payable | Prior1YearInstant | 15000000000 | JPY |
| Bonds payable | InterimInstant | 15000000000 | JPY |
| Long term loans payable | Prior1YearInstant | 30689000000 | JPY |
| Long term loans payable | InterimInstant | 40524000000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 8345000000 | JPY |
| Net defined benefit liability | InterimInstant | 8160000000 | JPY |
| Other ncl | Prior1YearInstant | 49228000000 | JPY |
| Other ncl | InterimInstant | 57852000000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 103264000000 | JPY |
| Noncurrent liabilities | InterimInstant | 121537000000 | JPY |
| Liabilities | Prior1YearInstant | 176683000000 | JPY |
| Liabilities | InterimInstant | 189154000000 | JPY |
| Capital stock | Prior1YearInstant | 13226000000 | JPY |
| Capital stock | InterimInstant | 13226000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |